Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cytokinetics Inc (NASDAQ:CYTK)

10.20
Delayed Data
As of 4:00pm ET
 +0.05 / +0.49%
Today’s Change
6.00
Today|||52-Week Range
13.45
-16.05%
Year-to-Date

Stock Price Forecast

The 7 analysts offering 12-month price forecasts for Cytokinetics Inc have a median target of 21.00, with a high estimate of 24.00 and a low estimate of 15.00. The median estimate represents a +105.88% increase from the last price of 10.20.

Analyst Recommendations

The current consensus among 6 polled investment analysts is to Buy stock in Cytokinetics Inc. This rating has held steady since February, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.57
Sales
$7.9M
Reporting Date
Apr 27

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -454.17%
 
 
 
 
 
 
Growthannually -620.51%
 
 
 
 
 
 

Sales

Growthquarterly -76.31%
 
 
 
 
 
 
Growthannually -63.47%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.